Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2FOSTAMATINIB DISODIUM

02 1OLUTASIDENIB

03 1PRALSETINIB

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : TAVALISSE

STLE Annual Meeting
Not Confirmed
arrow

Brand Name : TAVALISSE

STLE Annual Meeting
Not Confirmed
arrow

Rigel Pharmaceuticals

Dosage Form : TABLET; ORAL

Proprietary Name : TAVALISSE

Dosage Strength : EQ 100MG BASE

Approval Date : 2018-04-17

Application Number : 209299

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

02

Brand Name : TAVALISSE

STLE Annual Meeting
Not Confirmed
arrow

Brand Name : TAVALISSE

STLE Annual Meeting
Not Confirmed
arrow

Rigel Pharmaceuticals

Dosage Form : TABLET; ORAL

Proprietary Name : TAVALISSE

Dosage Strength : EQ 150MG BASE

Approval Date : 2018-04-17

Application Number : 209299

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

03

Brand Name : REZLIDHIA

STLE Annual Meeting
Not Confirmed
arrow

Brand Name : REZLIDHIA

STLE Annual Meeting
Not Confirmed
arrow

Rigel Pharmaceuticals

Dosage Form : CAPSULE; ORAL

Proprietary Name : REZLIDHIA

Dosage Strength : 150MG

Approval Date : 2022-12-01

Application Number : 215814

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

04

Brand Name : GAVRETO

STLE Annual Meeting
Not Confirmed
arrow

Brand Name : GAVRETO

STLE Annual Meeting
Not Confirmed
arrow

Rigel Pharmaceuticals

Dosage Form : CAPSULE; ORAL

Proprietary Name : GAVRETO

Dosage Strength : 100MG

Approval Date : 2020-09-04

Application Number : 213721

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank